House Passes New Hurdles For Opioid Drug Approvals At FDA
New opioid drugs could face additional steps for U.S. Food and Drug Administration approval and labeling under a bill the House approved on Wednesday, as part of a weeklong tear of...To view the full article, register now.
Already a subscriber? Click here to view full article